0000899243-18-010071.txt : 20180412
0000899243-18-010071.hdr.sgml : 20180412
20180412160856
ACCESSION NUMBER: 0000899243-18-010071
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180411
FILED AS OF DATE: 20180412
DATE AS OF CHANGE: 20180412
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grossi Federico
CENTRAL INDEX KEY: 0001720634
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 18752194
MAIL ADDRESS:
STREET 1: C/O APELLIS PHARMACEUTICALS, INC.
STREET 2: 6400 WESTWIND WAY, SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
BUSINESS PHONE: 502-241-4114
MAIL ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-04-11
0
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001720634
Grossi Federico
C/O APELLIS PHARMACEUTICALS, INC
6400 WESTWIND WAY, SUITE A
CRESTWOOD
KY
40014
0
1
0
0
See Remarks
Common Stock
2018-04-11
4
M
0
8500
3.20
A
8500
D
Stock Option (right to buy)
3.20
2018-04-11
4
M
0
8500
0.00
D
2024-12-11
Common Stock
8500
61823
D
This option was granted on December 12, 2014 and has vested as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.
Executive Vice President - Clinical Development
/s/ David Watson, attorney-in-fact for Federico Grossi
2018-04-12